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Abstract
Background: Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine are the most common form of medication
treatment for major depression. However, approximately 50% of depressed patients fail to achieve an effective treatment
response. Understanding how gene expression systems respond to treatments may be critical for understanding
antidepressant resistance.
Methods: We take a novel approach to this problem by demonstrating that the gene expression system of the dentate
gyrus responds to fluoxetine (FLX), a commonly used antidepressant medication, in a stereotyped-manner involving
changes in the expression levels of thousands of genes. The aggregate behavior of this large-scale systemic response was
quantified with principal components analysis (PCA) yielding a single quantitative measure of the global gene expression
system state.
Results: Quantitative measures of system state were highly correlated with variability in levels of antidepressant-sensitive
behaviors in a mouse model of depression treated with fluoxetine. Analysis of dorsal and ventral dentate samples in the
same mice indicated that system state co-varied across these regions despite their reported functional differences.
Aggregate measures of gene expression system state were very robust and remained unchanged when different microarray
data processing algorithms were used and even when completely different sets of gene expression levels were used for
their calculation.
Conclusions: System state measures provide a robust method to quantify and relate global gene expression system state
variability to behavior and treatment. State variability also suggests that the diversity of reported changes in gene
expression levels in response to treatments such as fluoxetine may represent different perspectives on unified but noisy
global gene expression system state level responses. Studying regulation of gene expression systems at the state level may
be useful in guiding new approaches to augmentation of traditional antidepressant treatments.
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Introduction
Measurement of changes in gene expression levels in response to
treatments is a commonly used approach to understanding
biological processes. This is because gene expression levels
frequently approximate protein levels, yet are much easier to
measure. This is particularly true at the global level with gene
expression profiling where the expression levels of nearly all genes
can be measured in a single experiment. However, measurements
of individual expression levels can also be problematic because of
the sensitivity of these measurements to a multitude of factors. For
instance differences in microarray platform and hybridization
batch effects have often been blamed for difficulty in reproducing
identified gene lists[1,2]. Thus, there is a healthy skepticism about
gene expression results and an expectation that results for
individual genes will be confirmed with alternative methods. By
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contrast, we have found that the noisiness of gene expression
measurements at the individual gene expression level does not
translate to the systems level, where measurements of global gene
expression system state, an aggregate measure of the behavior of
thousands of gene expression levels such as those occurring during
the progression of a developmental gene expression program, are
highly robust[3,4]. For instance, we, and others, have used
covariance-based analyses such as principal components analysis
(PCA), often referred to as singular value decomposition (SVD)
when applied to gene expression data, to quantify the aggregate
behavior of covarying gene expression levels[4,5,6,7,8,9]. Such
methods reduce thousands of gene expression measurement into
principal components scores that describe the central tendency of
large groups of covarying genes.
Because stereotyped gene expression programs, such as those
occurring during development or in response to stimuli, are
characterized by a large fraction of monotonically changing gene
expression levels, we have found that the first principal component
score (PCA1), which describes the monotonically changing
fraction of genes, can be used to quantify the progression of gene
expression programs under multiple conditions[4]. For instance,
when principal components analysis (PCA) was performed on gene
expression data from time course gene expression profiling
experiments, such as during the development of neuronal subtypes
or during the activation of T cells, the first principal component
score (PCA1), a single measure for each microarray, changed
monotonically across time[4]. Thus, PCA1 could arrange micro-
arrays into their correct temporal order without temporal
information. This indicated that PCA1 could be used as a
quantitative measure of gene expression system states with respect
to their sequential position along steterotyped gene expression
programs. Because gene expression programs involve thousands of
gene expression levels we have found that PCA1 as a measure of
system state is very robust. In fact, PCA can be performed on any
randomly chosen 2% of genes to give nearly identical values
(Pearson r correlation coefficients .0.95) for PCA1 using
independent groups of non-overlapping genes. Thus, PCA1
summarizes the behavior of thousands of covarying montonically
changing gene expression levels into continuous quantitative
measures that describe the aggregate state of gene expression
systems as they progress along stereotyped gene expression
programs.
System state measurements such as PCA1 are believed to be so
robust because gene expression systems are hierarchical with
multiple levels of cross-regulation[10]. Noise develops in hierar-
chical systems and can be transmitted from higher to lower levels,
but importantly noise in expression levels is layered on top of
biological information about the state of gene expression systems.
Consequently, when analyzed in the aggregate, thousands of
biologically noisy gene expression levels and their technically noisy
measurements can nonetheless be reduced to extremely robust
measures describing the overall state of a gene expression
system[3,4]. Measurement of gene expression system state is not
only useful because it is robust, but also because these robust
measures incorporate complex and often difficult to measure
details of dynamic gene expression systems into single measures
which can then be easily related to higher level processes such as
cell function, animal behavior, or disease state. For example,
variability across development in the global state of the gene
expression system of fast-spiking interneurons (FS cells), as
measured by PCA1, was related to developmental variability in
FS cell function[4,11]. Interestingly, we found that variability in
the maturity of the FS cell gene expression system was not solely
determined by the age of an individual[3]. Suggesting there was
pathological importance to variability in the maturity of the FS cell
program we found after controlling for age that the global state of
the FS cell gene expression system was immature in the cortex of
humans with autism, schizophrenia, and bipolar disorder[3].
Thus, system state measurements supported the hypothesis that
immaturity of specific cell types in specific brain regions might
contribute to neuropsychiatric disease.
Along similar lines we reasoned that using PCA1 to measure the
global state of the gene expression system in the dentate gyrus, a
brain region implicated in the pathogenesis of depression and the
treatment response to antidepressant medication, might provide
novel information about antidepressant treatment responses at the
gene expression system level. Specifically we hypothesized that
aggregate gene expression level responses to antidepressant
treatment could be described at the system level and that
variability in the state of the dentate gene expression system
might explain observed variability in behavioral responses to
treatment. Supporting these hypotheses, we describe a relationship
between the global state of the dentate gyrus gene expression
system and variability in antidepressant-sensitive behaviors in
response to fluoxetine. Results indicate that state variability
involves large-scale changes in thousands of genes, can be robustly
measured with gene expression profiling combined with PCA, and
can be used to relate variability in system state to higher order
processes such as behavior and treatment response.
Materials and Methods
Ethics Statement
All animal work was conducted in compliance with the NIH
laboratory animal care guidelines and with protocols approved by
the Institutional Animal Care and Use Committee at Columbia
University.
Mice
Adult male C57BL/6Ntac mice were purchased from Taconic
Farms (Germantown, NY, USA). All mice were 7–8 weeks old and
weighed 23–35 g at the beginning of the treatment, were
maintained on a 12L:12D schedule, and were housed five per
cage. Food and water were provided ad libitum.
Drugs
Treatments were carried out as previously described[12].
Corticosterone (CORT) (from Sigma, St. Louis, MO) was
dissolved in vehicle (0.45% beta-cyclodextrin, Sigma, St Louis,
MO). Fluoxetine hydrochloride (160 ug/ml) was purchased from
Anawa Trading (Zurich, Switzerland). Corticosterone (35 ug/ml)
was delivered alone or in the presence of antidepressant in opaque
bottles to protect it from light, and was available ad libitum in the
drinking water. In a separate cohort of mice serum levels of
norfluoxetine, the active metabolite of fluoxetine, were compara-
ble across mice treated with fluoxetine and CORT in the drinking
water, and serum norfluoxetine levels were not related to behavior
(Figure S3).
Behavioral Testing
Behavioral tests were carried out as previously described[12].
The novelty suppressed feeding test (NSF) was done first, followed
by the forced swim test (FST) 4 days later. The NSF test was
carried out during an 8 min period as previously described[12].
Mice were exposed to twenty-four hours of food deprivation.
Latency to eat a food pellet in the center of a brightly lit box was
measured. For the FST, mice were placed into plastic buckets
(19 cm diameter, 23 cm deep, filled with 23uC–25uC water) and
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videotaped for the entire 6-minute session. Immobility was
considered to be when animals floated with no attempt at
swimming.
RNA extraction and microarray experiments
To allow for stress related to the FST to subside, mice were
maintained on their drug regimen and left undisturbed one week
following the end of behavioral experiments. Mice were then
sacrificed and whole brains were dissected and placed into chilled
ACSF solution for five minutes. The hippocampus was then
dissected while maintaining the correct dorsal-ventral orientation.
Transverse slices were cut through the hippocampus along the
septotemporal axis and the molecular and granular layers of the
dentate gyrus were microdissected from these transverse slices.
Bilateral dentate gyri from dorsal or ventral sections of each mouse
were combined into separate RNase free microcentrifuge tubes for
each region. All samples were then immediately flash frozen and
stored at 280 degrees Celsius. For RNA isolation, an appropriate
volume of lysis buffer (Qiagen RNeasy kit) was added to the frozen
tissue, which was then homogenized with a handheld tissue
homogenizer. RNA was isolated following the manufacturer’s
instructions. Approximately 500 ng of high quality RNA was
isolated per sample and prepared for a small scale Affymetrix
protocol (requiring 100 ng). RNA was then submitted to
Expression Analysis (expressionanalysis.com) for microarray pro-
cessing. All samples were processed in parallel and hybridized in a
single batch using Affymetrix 430_2 39 expression arrays.
Expression Analysis is Clinical Laboratory Improvement Amend-
ments (CLIA) and Good Laboratory Practices (GLP) compliant
and incorporates all CLIA and GLP quality control measures
(QC) into its workflow (http://expressionanalysis.com/quality/
quality_systems/).
Microarray data processing
Affymetrix ‘‘.CEL’’ files were imported into Affymetrix Expres-
sion Console. Data processing for expression levels was performed
with Robust Multiarray Analysis (RMA) and MicroArray Analysis
Suite 5 (MAS5). Present calls were obtained from MAS5 analysis.
Data were deposited in the Gene Expression Omnibus (GEO)
accession number GSE43261.
Principal components analysis (PCA)
Five non-overlapping groups of expression levels from 2000
probe sets were each subjected to principal components analysis
(PCA). Probe set groups were selected based on the order of their
probe set ID numbers, i.e. Group 1 was probe sets #1-2000,
Group 2 was probe sets #2001-4000, etc. PCA was performed in
MATLAB on Z-scored data. Similar results could be obtained by
randomly shuffling the probe sets before selecting them based on
order, indicating that the order assigned by Affymetrix does not
impact our results. The first principal component score (PCA1)
was used as a measure of gene expression system state for each
microarray. PCA1 from principal components analysis of each of
the five groups of probe sets were nearly identical (Figure 1e–f).
Correlations
Pearson correlations were used for data with normal distribu-
tions and Spearman correlations were used when data was not
normally distributed.
Statistics
Students’ t-tests and correlation measures were calculated in
Prism (GraphPad, La Jolla, CA).
Connectivity analysis
An adjacency matrix was constructed from cross-correlations of
gene expression levels. Genes were considered connected if they
had a significant (p,0.001) cross-correlation. Connectivity was
calculated as the number of connections/total number of genes.
Euclidean distance
Euclidean distance was calculated in Matlab using the ‘‘pdist’’
function and measured relative to the transcriptome with the
lowest value for PCA1.
David Functional Annotation Clustering
Functional Annotation Clustering was done using the David
Analysis Wizard (http://david.abcc.ncifcrf.gov/tools.jsp). Cluster-
ing analysis begins with a traditional pathway analysis in which a
specified group of gene expression level identifiers is evaluated for
pathway enrichment relative to background using a modified
Fisher’s exact test (EASE score). Clustering analysis then uses the
redundancy of annotations to group pathways, with EASE scores
below a cutoff, into biologically meaningful groups based on
similarity of annotations. The Group Enrichment Score measures
the geometric mean (in negative log10 scale) of the group
member’s p-values in the cluster. For example, an Enrichment
Score of 5 would mean the average p-value for the pathways in a
cluster was 10-5. Default setting modifications included: 1)
Entering our own background expression levels, which was limited
to genes that were defined as present by Affymetrix MAS5 analysis
in greater than 50% of samples; 2) In order to reduce annotation
redundancy, annotation databases were limited to one Functional
Category, SP_PIR_KEYWORDS, and two ontology categories,
GO_Biological Process and GO_Molecular Funtion; 3) To
decrease the number of non-specific pathways used for clustering,
the EASE cutoff was decreased to 0.05; and 4) To increase the
clustering of related annotations, the similarity threshold was
decreased to 0.35. All other values were left at their defaults.
Finally, because there are often multiple probesets for each gene,
probe sets were summarized into single expression values for each
gene using a weighted average based on the proportion of present
calls for a given probe set. Therefore, all gene lists entered into
DAVID had single expressions values for each gene to prevent bias
towards genes with multiple probe sets and to make sure genes
were not duplicated across lists.
Results
Behavioral responses to fluoxetine (FLX) are variable in a
mouse model of depression
Thirty mice were treated with chronic corticosterone (CORT),
which induces depression-like behaviors with increased immobility
in the Forced Swim Test (FST) and anxiety-like behavior with
increased latency to eat in the Novelty Suppressed Feeding Test
(NSF). These features can then be reversed with chronic
antidepressant treatment[12,13]. CORT was combined with
vehicle (15 mice) or FLX (15 mice) for 21 days. Following
treatment, mice were subjected to behavioral tests in the FST and
NSF. At the group level, FLX significantly decreased immobility in
the FST (p,0.005) and decreased latency to eat in the NSF (p,
0.005) (Figure S1a–b). At the individual level, there was substantial
inter-individual variability in the behavioral responses to fluoxe-
tine. In general, immobility and latency were correlated (Figure
S1c, Spearman r= 0.47, p= 0.008). However, a minority of mice
(4 out of 15) appeared to respond to FLX in the NSF but not in the
FST. Because we were interested in relating general variability in
antidepressant-sensitive behaviors to global gene expression system
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level responses, behaviorally ambiguous mice were not used for
microarray experiments described below, such that 11 out 15
fluoxetine treated mice were used for microarrays. In the future it
may be interesting to evaluate ambiguous responders, as they
could be useful in dissociating anti-depression-like effects from
anti-anxiety-like effects. Eight randomly chosen mice not treated
with FLX were used as representative controls for microarray
studies.
Figure 1. Principal components analysis generates a robust meaure (PCA1) of gene expression system state. Panel (a) plots the
proportion of variance explained by principal components 1–4. Panel (b) is a bivariate plot of PCA1 values obtained from PCA done on all samples
grouped together (x-axis) versus PCA1 from separate PCAs on samples grouped by region (y-axis) (r = 0.99, p,0.001). Panel (c) shows that the data
processing algorithm used has no effect on values for PCA1 (r = 1.00, p,0.001). Panel (d) compares PCA1 values of dorsal and ventral dentate from
the same mice (r = 0.97, p,0.001). Panels (e–f) are cross-correlation tables for PCA1 values obtained from PCA on independent groups of 2000
expression levels/group in dorsal (e) and ventral (f) dentate samples. Panel (g) plots gene connectivity (x-axis) against the correlation coefficient of
genes with PCA1 demonstrating that more connected genes follow more closely with PCA1. Panel (h) plots PCA1 versus the Euclidean distance of
transcriptomes from the transcriptome with the lowest value for PCA1 (open circle).
doi:10.1371/journal.pone.0085136.g001
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Similar gene expression responses to fluoxetine found in
dorsal and ventral dentate gyrus
Gene expression microarrays were used for whole transcriptome
profiling of dentate gyrus tissue. Based on research demonstrating
a distinction between dorsal (spatial) and ventral (emotional)
hippocampal information processing[14,15,16,17,18,19], the bi-
lateral dentate gyri were separated into dorsal and ventral sections
from each mouse. Log-fold changes in gene expression levels in
response to FLX were compared between the dorsal and ventral
dentate. To our surprise, responses were virtually identical across
regions (Figure 2, Pearson R=0.89, p,0.0001). The overall gene
expression response involved thousands of genes with 46% of
genes significantly changing expression levels in at least one region
and 21% significantly changing in both regions. Supporting that
the same response was occurring in both regions, 94% of genes
that were significant in at least one region changed in the same
direction in the other region, and 99.9% of genes that were
significant in both regions changed in the same direction.
Variability in gene expression levels in the dentate gyrus
results from variability in the global state of the dentate
gyrus gene expression system
Variability in gene expression levels can result from variability
in the state of expression systems, which often involves stereotyped
changes in thousands of genes, commonly referred to as gene
expression programs[4,20,21]. We, and others, have found that
covariance-based data analyses such as principal components
analysis (PCA) can be used to study global changes in gene
expression systems[4,22,23,24,25]. Though these methods are
frequently used with time course data, variability in the state of
gene expression systems, irrespective of the origin of variability,
can be detected with PCA[4]. Previous work indicated that the
first principal component score (PCA1) measures the global state
of gene expression systems under many conditions[3,4]. For
example, PCA1 from developmental time course studies always
increased monotonically over time, thus defining the global state of
the system across development[4]. We, therefore, hypothesized
that such an approach could quantify variability in the state of the
dentate gene expression system in our experimental samples.
PCA was performed on gene expression data from multiple
samples from FLX- treated and untreated mice that were grouped
by region (dorsal or ventral dentate). PCA1 values, which
explained approximately 20% of the variance in gene expression
data (Figure 1a), for each sample were the same whether PCA was
performed on all samples together or performed separately on
samples grouped by region (Figure 1b, Pearson R=0.99, p,
0.0001). PCA1 values were also identical when microarray data
were processed and summarized with RMA or MAS5 algorithms
(Figure 1c, Pearson R=0.99, p,0.0001). As was suggested by the
dorsal/ventral regional comparisons above, PCA1 was the same
across regions (Figure 1d, Pearson R=0.97, p,0.0001). As
previously reported, PCA was not affected by differences in the
probe sets used for the principal components analysis. PCA
performed on five independent groups of 2000 expression levels
yielded nearly identical values for PCA1 (Figure 1e-f, R.0.97, p,
0.001). The number of genes used was arbitrary and similar results
were obtained with subsets of 500, 1000, and 4000 probe sets (not
shown).
Principal components scores, sometimes referred to as Eigen-
genes[5,7,22,26], describe the central tendency of gene expression
levels that correlate with them, and therefore, represent an
aggregate measure of large-scale stereotyped changes in gene
expression systems. In this regard PCA1 was significantly positively
correlated with the expression levels of greater than 6000 probe
sets representing greater than 4000 unique genes and negatively
correlated with nearly 7000 probe sets representing approximately
4,500 unique genes. As above with fluoxetine-induced gene
expression changes, a high degree of overlap in expression levels
that correlated with PCA1 was present between dorsal and ventral
dentate samples. Thousands of expression levels, including 57% of
expression levels detected as present, significantly correlated with
PCA1 in at least one region and 28% were significantly correlated
in both regions. Consistent with the hypothesis that genes were
changing in the same way in both regions, 92% of expression levels
that significantly correlated with PCA1 in at least one region
correlated in the same direction in the other region, and 99.8% of
expression levels that were significant in both regions were
correlated in the same direction.
High levels of covariance occur as gene expression systems vary
because these systems have hierarchical structures [10,27,28,29].
Thus, in the current experiment the connectivity of genes, a
measure of a gene’s position in a hierarchy with highly connected
genes at the top of hierarchical systems, was related to the degree
to which genes followed PCA1. Regardless of the direction of the
correlation, more connected genes followed more closely with
PCA1 (Figure 1g). Further demonstrating that PCA1 measured
global changes in system state, the Euclidean distance, a global
measure of dissimilarity, from the transcriptome with the lowest
value for PCA1 was linearly related to PCA1 (Figure 1h).
Levels of antidepressant-sensitive behaviors relate to the
global state of the dentate gene expression system
Because fluoxetine-induced gene expression changes and PCA1-
correlated expression levels both included greater than 50% of all
present genes and were similar across dorsal and ventral dentate, it
was predicted that genes induced by fluoxetine would be the same
as those following PCA1. In fact, 90% of gene expression levels
significantly altered by fluoxetine in at least one region of the
dentate were also significantly correlated with PCA1 in at least one
region. In all cases, genes that were significantly positively
correlated with PCA1 were upregulated by fluoxetine and vice
Figure 2. FLX-induced gene expression changes were the same
in dorsal and ventral dentate samples. Gene expression profiling
of the dorsal and ventral dentate gyrus of mice treated with FLX+CORT
were compared to samples from mice treated with CORT only. Figure
plots the log2-fold changes in gene expression levels from FLX+CORT
samples relative to CORT only samples in dorsal (x-axis) versus ventral
(y-axis) dentate gyrus. Log2 fold changes in gene expression levels were
highly correlated (Pearson r = 0.89, p,0.0001) across regions.
doi:10.1371/journal.pone.0085136.g002
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versa. Thus, PCA1 measured aggregate changes in thousands of
genes responding to fluoxetine and suggested PCA1 could be used
to relate variability in dentate gyrus gene expression system state to
variability in antidepressant-sensitive behaviors in response to
fluoxetine. Regression analyses indicated that for both dentate
regions and for both behavioral measures there were highly
significant correlations between system state (PCA1) and behavior
(Figure 3: Immobility in the FST – ventral: Spearman r=20.63,
p = 0.004***, dorsal: Spearman r=20.63, p = 0.004***; Latency
to eat in the NSF – ventral: Spearman r=20.79, p,0.001***,
dorsal: Spearman r=20.81, p,0.001***).
Pathway analysis of PCA-identified genes confirms
measurement of a biological signal
Much concern exists about gene expression profiling studies,
particularly microarray studies, and a potential for type 1 errors
and/or technically related gene expression changes being mistaken
for biologically related changes. With traditional gene expression
approaches these concerns are addressed with the use of
alternative quantitative measures such as real-time PCR or protein
level quantification. However, our measure, PCA1, captures the
behavior of thousands of genes. Validating any number of these
genes still would not validate that PCA1 truly measured a
biologically meaningful change in the dentate gene expression
system. To address this question, we used Functional Annotation
Clustering to demonstrate that PCA1-related genes fell into
biologically cohesive groups, whereas, PCA1-unrelated genes did
not, or at least to a much lesser degree. Enriched annotation
pathways were identified using pathway analysis with the David
Functional Annotation Tool and clustered by similarity into
groups with shared biological themes. Enrichment Scores, which
are negative log10 measures of the average significance of multiple
related annotation pathways in a cluster, were used to quantify the
significance of the biological annotation clusters (see Methods). A
large cluster of 26 annotation pathways with an enrichment score
of 6.0 was identified for significantly positively PCA1-correlated
genes and was centered on the biological theme of membrane
signaling (Table S1). Interestingly, BDNF, which was highly
correlated with PCA1 (Figure S2: r = 0.93, P,0.001) and has been
widely reported to be an important player in antidepressant
treatment responses[30,31,32,33], was identified in this cluster.
The remaining two out of the top three clusters for this group of
genes all had enrichment scores greater than 3.8. For the
significantly negatively correlated group of genes the top
Enrichment Score of 3.45 was for a cluster of annotation pathways
centered on the biological theme of ribosomes and translation
(Table S2). For non-significantly correlated genes the highest
Enrichment Score for either group was 2.1, indicating that p-
values for enriched pathways in groups of genes related to PCA1
were much more significant than pathways in groups of PCA1-
unrelated genes. To further support the validity of identified
clusters, groups of genes were randomly split in half and the split
groups of genes were analyzed separately. Two out of the top three
clusters with the highest enrichment scores for both significantly
positively and negatively correlated genes demonstrated the same
cluster themes and many of the same pathways in the split groups
of genes even though these groups did not share any of the same
genes (Table S3). On the other hand, analysis of subgroups from
non-significant genes did not identify any shared clusters or shared
pathways. Of note, a list of all probe sets that were significantly
changed in response to fluoxetine in both the dorsal and ventral
dentate (Table S4) is provided for researchers who wish to
compare gene lists. Additionally, raw.CEL files have been
deposited in the Gene Expression Omnibus (GEO) accession
number GSE43261.
Figure 3. PCA1 is inversely related to levels of antidepressant-sensitive behaviors. Panels (a–b) plot immobility in the FST (y-axis) against
PCA1 (x-axis) for the dorsal (a, Spearman r =20.63, p = 0.004) and ventral (b, Spearman r =20.63, p = 0.004) dentate gyrus samples. Panels (c–d) plot
latency to eat in the NSF (y-axis) against PCA1 (x-axis) for the dorsal (c, Spearman r =20.81, p = 0.004) and ventral (d, Spearman r =20.79, p = 0.004)
dentate gyrus samples.
doi:10.1371/journal.pone.0085136.g003
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Discussion
Principal components analysis, also known as singular value
decomposition (SVD), has been widely used to analyze gene
expression data[5,9]. Historically these techniques have been used
to identify and classify groups of genes that behave in a coherent
manner. In this regard, much emphasis has been placed on
validating biological covariance. For instance, techniques such as
weighted gene network connectivity analysis (WGNCA)[22,23]
and gene expression clustering methods[28], start with PCA or
similar methods, but then refine groups of covarying genes by
using dissimilarity measures to further divide groups of covarying
genes into subgroups of genes with even more similar dynamics.
WGNCA goes even a step further by refining gene networks using
known biological interactions of gene-encoded proteins to give
added weight to expression level relationships that have support at
the protein interaction level. Thus, the focus of these techniques is
to define, with as much confidence as possible, groups of genes
that biologically covary to better understand the nature of the
responses being studied. By contrast, we focus on PCA1 itself as a
measure of an overall gene expression system state and go to great
lengths to show that the same values for PCA1 were obtained no
matter what genes (any random 2% of genes), data summarization
method (MAS5 vs. RMA), or sample grouping (by region or all
together) was used. Thus, while great care must be taken when the
goal is to accurately determine which individual genes are truly
parts of a co-regulatory group, it is paradoxically very difficult not
to get the same values for system state measures no matter what
method is used. We interpret this to mean that there is a higher
level of organization for co-regulatory networks at the system state
level and that PCA1 quantifies this higher organizational state.
Quantifying system states demonstrates the continuity of state
transitions, lends itself to robustly quantifying the extent of global
system level changes, and helps relate system state changes to
higher order processes such as disease, behavior, and treatment
response.
We feel system state measures are particularly important
because they measure an aspect of gene expression system
regulation that could potentially be exploited for treatment
benefit. While it is unclear in the current study why certain
individuals responded differently to antidepressant treatment, the
relationship between treatment, behavior, and systemic transcrip-
tional responses in a brain region implicated in antidepressant-
sensitive behaviors strongly suggests that the observed gene
expression response has some functional relevance to treatment
effects. Importantly, if gene expression changes are causally related
to a treatment responses and if gene expression changes occur as
part of large-scale changes in gene expression systems then
understanding how to augment therapeutically beneficial changes
in gene expression systems becomes an important research goal.
Though somewhat counterintuitive and paradoxical, the more
important an aggregate systemic gene expression response is to
observed treatment effects, the less important to treatment
strategies it may be to understand the details of the response.
For instance, large-scale modulation of epigenetic regulators, such
as with histone deacetylase inhbitors (HDACi), is often associated
with the enhancement of multiple biological responses from
memory formation[34,35,36] to immune responses[37,38,39,40]
to cancer therapy [41,42,43]. Using HDACi as an example, gene
expression system state measures provide a method to determine
whether HDACi act by modulating endogenous gene expression
system responses for therapeutic benefit. If this is the case, then an
important goal becomes how to target these system-modulating
therapies to brain regions where global chromatin modification
would be beneficial, while avoiding areas where chromatin
restructuring would be unnecessary or potentially harmful. Such
a localizing strategy is well established within oncology, which may
be a useful source for future guidance. In other words, if a response
in its entirety can be modulated, measured, and can elicit
therapeutic effects, then understanding the details of the response,
while potentially interesting, is not necessary to develop rational
treatment strategies. It is only when an aggregate gene expression
system level response does not explain a biological response or
cannot be targeted or manipulated for therapeutic benefit that
system details offer a potential therapeutic work-around. While it
is tempting to suggest that treatments targeted to limited aspects of
system-wide responses may have lower risk of side-effects, it can
alternatively be argued that mimicking healthy large-scale
biological responses may be the most naturalistic and effective
therapeutic strategy. System state measures provide a useful tool to
evaluate these contrasting perspectives.
It is also important to discuss our approach to experimental
validation, which was different from traditional gene expression
studies and did not involve real-time PCR or protein quantifica-
tion methods. These methods are typically used to validate
changes in specific genes to define which gene expression changes
merit an investment of time and resources for further study.
Validating a systemic measure, however, cannot be accomplished
at the level of individual genes and required different approaches
to support results. One validation approach we used was
subsampling of independent groups of genes to show that PCA1
values obtained using any subsample of genes were the same as
PCA1 values from other completely independent subsets of genes.
Subsampling demonstrates that PCA1 measures a systemic
property that is widely distributed across the transcriptome.
Similarly we showed that the choice of microarray data processing
algorithms did not affect results even though processing algorithms
are known to give different results at the level of individual genes
and in the reverse engineering of gene expression networks[44].
Thus, redundant information about the state of the gene
expression systems was able to overcome potential effects of
variability in individual gene expression levels introduced by
processing algorithms. Another way we supported our results was
to demonstrate that genes that correlated with PCA1 were
enriched for biological pathways relative to PCA1-unrelated
genes. This approach indicated that PCA1 was unlikely to be
measuring a technical artifact, which should not enrich for
biological pathways. As discussed above, the importance of
measuring gene expression system state is not to highlight details
of the response, thus, the purpose of pathway analysis in this study
was not to focus on the identified pathways, but rather to address
potential concerns that we were measuring a technical artifact.
The finding that PCA1-related genes were predominantly the
same genes that were induced by fluoxetine demonstrated in
another way that PCA1-related genes were in the aggregate part of
a biological response. Finally, the relationship of PCA1 to two
antidepressant-sensitive behavioral measures added another level
of support to the idea that gene expression system states might
contribute to behavioral effects, which suggests future experiments
designed to understand whether system states could be modulated
for therapeutic benefit.
Comparing gene expression measures across dorsal and ventral
dentate was also interesting. There was a high level of covariance
across these spatially, and reportedly functionally, distinct subre-
gions [14,15,16,17,18,19,45,46]. This included covariance in
system state measures and individual gene expression levels. In
the current experiment all mice were exposed to systemic
treatments (CORT or CORT +FLX), therefore, it is possible that
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state covariance across regions only occurs in the presence of
systemic signals. Thus, it would be interesting to study whether
regional covariance of system state exists under more naturalistic
conditions. Nonetheless, the current experiment demonstrates that
at least with systemic exposures such as treatments, dentate regions
can be synchronized at the gene expression system state level.
Thus, if antidepressant treatments are able to impact different
aspects of cognitive processing that are subserved by the dorsal and
ventral dentate, these effects are likely the consequence of the same
gene expression level changes having different effects based on
cellular location and circuit level integration. Another consider-
ation with respect to our systemic treatments is their delivery via
drinking water. Separate studies documented that comparable
serum levels of norfluoxetine, the active metabolite of fluoxetine,
were reached in all CORT + FLX-treated mice and that there was
not a relationship between norfluoxetine levels and behavioral
responses (Figure S3). Importantly, the goal of the current study
was not to determine which factors, e.g. dosing, epigenetic
differences, etc. contributed to variability in antidepressant-
sensitive behaviors. The variability, however it was generated,
was used to demonstrate covariance of systemic gene expression
measures with behavior. Follow up studies might include
determining whether variability in behavioral responses induced
by different factors such as variable dosing [47], genetic
factors[48,49,50], or epigenetic factors [51,52,53,54] would
demonstrate the same relationship between dentate system state,
treatment, and behavior. Such a convergent relationship between
dentate system state and treatment response variability would help
prioritize gene expression system state as a promising treatment
target. Similarly, it would be interesting to determine whether
gene expression system state measures in other brain regions also
covary with the current or other measures of behavior.
Another interesting question raised by our study is in what cell
type or types are gene expression systems changing? A relationship
between gene connectivity and gene expression system state
supports a hierarchical organization to system level changes,
however, a hierarchical data structure could be the product of
intra or inter-cell type signaling cascades or both. Fluoxetine has
been reported to have diverse effects in multiple cell types and
brain regions[31,32]. Therefore, cell type specific purification
techniques such as laser-capture or bacTRAP purification[49]
would be useful for future study of this interesting question.
In summary, our study applied a novel approach to gene
expression systems research to show that a gene expression system-
wide response in the dentate gyrus to fluoxetine involving
thousands of expression levels could be captured in a single robust
measure (PCA1) with PCA, which was significantly related to
variability in antidepressant-sensitive behaviors. These results and
our state measurement approach set the stage for future efforts to
determine mechanisms by which gene expression system state is
modulated by fluoxetine and other antidepressants. Such exper-
iments may include dentate-specific genetic [48,49,50] and/or
epigenetic [51,52,53,54] manipulations, which could help establish
a causal relationship of system state modulation to treatment
response variability and point the direction towards novel
augmentation strategies for individuals resistant to current
antidepressant treatments.
Supporting Information
Figure S1 Variability present in behavioral response to
fluoxetine. All mice (n = 30) were chronically (21 days) treated
with corticosterone (CORT) (35 ug/ml) in the drinking water.
Fifteen mice were also co-administered fluoxetine (FLX) (160 ug/
ml). Following chronic treatment mice were tested in the Forced
Swim Test (FST) and Novelty Suppressed Feeding paradigm
(NSF). At the group level FLX-treated mice demonstrated
significantly decreased latency to eat in the NSF (panel a: P,
0.005) and decreased immobility in the NSF (panel b: P,0.005).
At the individual level there was a significantly correlation between
latency to eat (x-axis) and immobility (y-axis) (Spearman r= 0.47,
p = 0.008). Four mice (Ambiguous – open triangles) appeared to
respond in the NSF but not in the FST. These mice were not used
for microarray experiments.
(DOCX)
Figure S2 BDNF expression levels were highly correlat-
ed with PCA1. Two probe sets for BDNF were present on the
Affymetrix microarray platform used in the current study.
Expression levels for these probe sets were highly correlated
(panel a, Spearman r= 0.99, p,0.0001). A single BDNF level for
the two probe sets was calculated as the average of log2
transformed mean-standardized expression levels. Average BDNF
levels were highly correlated with PCA1 (panel b, Spearmen
r = 0.93, p,0.0001).
(DOCX)
Figure S3 Serum norfluoxetine levels are similar across mice
that receive the same concentration of fluoxetine in drinking water
and are not related to levels of antidepressant sensitive behaviors.
A separate cohort of eighteen mice was treated for 21 days with
fluoxetine (160 ug/ml) in the drinking water. Serum norfluoxetine
levels were measured at the time of sacrifice. Panel (a) shows that
behavioral responses were variable and that latency to eat in the
NSF was correlated with immobility in the FST (Spearman
r= 0.64, p= 0.005). Panels (b–c) show that there were comparable
serum levels (575–725 ng/ml) of norfluoxetine in all mice and that
variability in levels was not related to behavioral measures.
(DOCX)
Table S1 Annotation Cluster analysis of PCA1-related
genes reveals a biological signal (positively correlated
genes). Functional Annotation Clustering was done on lists of
genes that were significantly positively correlated with PCA1.
Results were compared to Functional Annotation Clustering on
lists of genes that were non- significantly positively correlated with
PCA1. Gene lists were culled to identical sizes based on the
random removal of genes to make all lists contain 1,600 genes.
Gene lists were also split into random subgroups of 800 genes each
for independent analyses. When multiple probe sets were present
for genes, results were summarized to a single value based on a
weighted average with weights assigned by the percentage of
present calls across all samples. Table S1 shows the top 3
annotation clusters for significantly positively correlated genes (left)
and non- significantly positively correlated genes (right).
(DOCX)
Table S2 Annotation Cluster analysis of PCA1-related
genes reveals a biological signal (negatively correlated
genes). Functional Annotation Clustering was done on lists of
genes that were significantly negatively correlated with PCA1.
Results were compared to Functional Annotation Clustering on
lists of genes that were non- significantly negatively correlated with
PCA1. Gene lists were culled to identical sizes based on the
random removal of genes to make all lists contain 1,600 genes.
Gene lists were also split into random subgroups of 800 genes each
for independent analyses. When multiple probe sets were present
for genes, results were summarized to a single value based on a
weighted average with weights assigned by the percentage of
present calls across all samples. Table S2 shows the top 3
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annotation clusters for significantly negatively correlated genes
(left) and non- significantly negatively correlated genes (right).
(DOCX)
Tables S3 Annotation Cluster analysis of PCA1-related
genes reveals a biological signal (randomly split gene
lists). Functional Annotation Clustering was done on lists of
genes that were significantly positively or negatively correlated
with PCA1. Results were compared to Functional Annotation
Clustering on lists of genes that were non- significantly positively
or negatively correlated with PCA1. Gene lists were culled to
identical sizes based on the random removal of genes to make all
lists contain 1,600 genes. Gene lists were also split into random
subgroups of 800 genes each for independent analyses. When
multiple probe sets were present for genes, results were
summarized to a single value based on a weighted average with
weights assigned by the percentage of present calls across all
samples. Table S3 shows the similarity of annotation clusters and
pathways from randomly split lists (800 non-overlapping genes) of
significantly positively and negatively PCA1-correlated genes.
Shared pathways are highlighted in bold.
(DOCX)
Table S4 List of probe sets that were signicantly up- or down-
regulated in both the dorsal and ventral dentate in response to
fluoxetine. Lists are arranged in descending order according to
absolute average log-fold change across regions.
(DOCX)
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